Evidence map›Paper›PMID 27006131›Full record

ArticleInternational journal of cancer2016

Use of thermo-coagulation as an alternative treatment modality in a 'screen-and-treat' programme of cervical screening in rural Malawi.

Christine Campbell, Savel Kafwafwa, Hilary Brown, Graeme Walker, Belito Madetsa, Miriam Deeny, Beatrice Kabota, David Morton, Reynier Ter Haar, Liz Grant and 1 more

Abstract read
In one paragraph

Article in International journal of cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Christine CampbellUsher Institute for Population Health Sciences and Informatics, Teviot Place, University of Edinburgh, EH8 9AG, United Kingdom.ORCID 0000-0003-4868-0554
Savel KafwafwaNkhoma CCAP Hospital, PO Box 48, Nkhoma, Malawi.
Hilary BrownDepartment of Obstetrics and Gynaecology, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, United Kingdom.
Graeme WalkerDepartment of Obstetrics and Gynaecology, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, United Kingdom.
Belito MadetsaNkhoma CCAP Hospital, PO Box 48, Nkhoma, Malawi.
Miriam DeenyDepartment of Gynaecology, Stobhill Hospital, Glasgow, G21 3UW, United Kingdom.
Beatrice KabotaNkhoma CCAP Hospital, PO Box 48, Nkhoma, Malawi.
David MortonNkhoma CCAP Hospital, PO Box 48, Nkhoma, Malawi.
Reynier Ter HaarNkhoma CCAP Hospital, PO Box 48, Nkhoma, Malawi.
Liz GrantGlobal Health Academy, University of Edinburgh, 1 George Square, Edinburgh, EH8 9JZ, United Kingdom.
Heather A CubieGlobal Health Academy, University of Edinburgh, 1 George Square, Edinburgh, EH8 9JZ, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of cervical cancer in Malawi is the highest in the world and projected to increase in the absence of interventions. Although government policy supports screening using visual inspection with acetic acid (VIA), screening provision is limited due to lack of infrastructure, trained personnel, and the cost and availability of gas for cryotherapy. Recently, thermo-coagulation has been acknowledged as a safe and acceptable procedure suitable for low-resource settings. We introduced thermo-coagulation for treatment of VIA-positive lesions as an alternative to cryotherapy within a cervical screening service based on VIA, coupled with appropriate, sustainable pathways of care for women with high-grade lesions and cancers. Detailed planning was undertaken for VIA clinics, and approvals were obtained from the Ministry of Health, Regional and Village Chiefs. Educational resources were developed. Thermo-coagulators were introduced into hospital and health centre settings, with theoretical and practical training in safe use and maintenance of equipment. A total of 7,088 previously unscreened women attended VIA clinics between October 2013 and March 2015. Screening clinics were held daily in the hospital and weekly in the health centres. Overall, VIA positivity was 6.1%. Almost 90% received same day treatment in the hospital setting, and 3- to 6-month cure rates of more than 90% are observed. Thermo-coagulation proved feasible and acceptable in this setting. Effective implementation requires comprehensive training and provider support, ongoing competency assessment, quality assurance and improvement audit. Thermo-coagulation offers an effective alternative to cryotherapy and encouraged VIA screening of many more women.

Indexed as

Early Detection of CancerElectrocoagulationMass ScreeningRural PopulationAdolescentAdultAgedAged, 80 and overFemaleFollow-Up StudiesHIV InfectionsHumansMalawiMiddle AgedRisk FactorsUterine Cervical Neoplasmsablative treatmentcervical screening‘screen and treat’thermo-coagulationVIA

Identifiers

PMID27006131
PMCPMC5084797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.